
CB1R Allosteric modulator 3
CAS No. 2633686-36-7
CB1R Allosteric modulator 3( —— )
Catalog No. M35571 CAS No. 2633686-36-7
CB1R Allosteric modulator 3 is a potent CB1R modulator that inhibits cAMP and β-Arrestin and can be used for the study of obesity and nicotine addiction.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 53 | Get Quote |
![]() ![]() |
5MG | 77 | Get Quote |
![]() ![]() |
10MG | 132 | Get Quote |
![]() ![]() |
25MG | 214 | Get Quote |
![]() ![]() |
50MG | 319 | Get Quote |
![]() ![]() |
100MG | 464 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCB1R Allosteric modulator 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB1R Allosteric modulator 3 is a potent CB1R modulator that inhibits cAMP and β-Arrestin and can be used for the study of obesity and nicotine addiction.
-
DescriptionCB1R Allosteric modulator 3 is a CB1R positive allosteric modulator. CB1R Allosteric modulator 3 has potent inhibition of cAMP and β-Arrestin with EC50 values of 0.018 μM and 1.241 μM, respectively.
-
In VitroCB1R Allosteric modulator 3 (compound 44) (0.10 nM-10 μM, 30 min) has potent inhibition of cAMP and β-Arrestin with EC50 values of 0.018 μM and 1.241 μM, respectively.CB1R Allosteric modulator 3 can enhance CB1R ago-PAM activity because of small lipophilic functional groups on the ortho-position of the GAT211 site-III phenyl ring.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetcAMP
-
RecptorcAMP | Cannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2633686-36-7
-
Formula Weight376.84
-
Molecular FormulaC22H17ClN2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (265.36 mM; Ultrasonic )
-
SMILESC(CN(=O)=O)(C1=C(NC=2C1=CC=CC2)C3=CC=CC=C3)C4=C(Cl)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Peter C Schaffer, et al. Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility. Bioorg Med Chem. 2020 Nov 1;28(21):115727. ?
molnova catalog



related products
-
ESI-05
ESI-05 is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation.
-
I942
I942 is a novel, selective ACyclic nucleotide (NCN) EPAC1 agonist that activates exchange proteins to regulate inflammatory gene expression in human umbilical blood tubes and inhibit pro-inflammatory cytokine signaling associated with cardiovascular disease.
-
CE3F4
CE3F4 is a selective antagonist of exchange protein directly activated by cAMP.